JCAP News and Press, Jernigan Capital Inc.

2026-03-12 21:43:02 ET More on Jefferson Capital, Inc. Jefferson Capital, Inc. (JCAP) Q4 2025 Earnings Call Transcript Jefferson Capital prices $205M stock offering at $20.50 per share Jefferson Capital stockholders plan secondary offering; company to repurchase shar...

2026-03-12 21:42:28 ET Jefferson Capital, Inc. (JCAP) Q4 2025 Earnings Call March 12, 2026 5:00 PM EDT Company Participants David Burton - President, CEO & Chairman Christo Realov - CFO & Treasurer Conference Call Participants David Scharf - Cit...

2026-03-12 16:25:11 ET More on Jefferson Capital, Inc. Jefferson Capital prices $205M stock offering at $20.50 per share Jefferson Capital stockholders plan secondary offering; company to repurchase shares Historical earnings data for Jefferson Capital, Inc. ...

Record Quarterly Collections Grow 41% to $245.3 Million and Record Deployments Grow 6% to $380.5 Million Fourth Quarter Pre-tax Income up 50% to $44.1 Million with Net Income of $37.7 Million and EPS of $0.58 Fourth Quarter Adjusted Pre-tax Income up 15% to $51.1 Million with Adjusted Net...

EHang Holdings Limited (EH) is expected to report $-0.06 for Q4 2025 McEwen Inc. (MUX) is expected to report $0.25 for Q4 2025 Hannover Ruck SE ADR - Level I (HVRRY) is expected to report $1.03 for Q4 2025 VAALCO Energy Inc. (EGY) is expected to report $0.02 for Q4 2025 Full Truck...

2026-03-06 14:03:28 ET John Hecht from Jefferies issued a price target of $29.00 for JCAP on 2026-03-06 16:29:00. The adjusted price target was set to $29.00. At the time of the announcement, JCAP was trading at $21.535. The overall price target consensus is at $26.33 wi...

MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. (NASDAQ: JCAP) (“Jefferson Capital”) , a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced that it will release financial results for the ...

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...

Travere Therapeutics Inc. (TVTX) is expected to report $0.03 for Q4 2025 Teck Resources Ltd (TECK) is expected to report $0.59 for Q4 2025 Heidmar Maritime Holdings Corp. (HMR) is expected to report $0.05 for Q4 2025 Endava plc American Depositary Shares (each representing one Class A...

Baxter International Inc. (BAX) is expected to report $0.53 for Q4 2025 Nova Ltd. (NVMI) is expected to report $1.94 for Q4 2025 West Pharmaceutical Services Inc. (WST) is expected to report $1.83 for Q4 2025 Universal Logistics Holdings Inc. (ULH) is expected to report $-0.05 for Q4 ...